MDY's chief exec steps down to save costs
This article was originally published in Clinica
Executive Summary
MDY Healthcare, an investor in healthcare companies, has denied that the departure of the company's chief executive Charles Spicer could signal trouble within the organisation. London-based MDY announced on February 20 that following a review of the firm's operations, it concluded that a chief executive was "no longer required" and was eliminating the position as part of a wider-scale cost-cutting programme.